Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q4 2022
Institutional positions in Cidara Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- 0 vs. Q3 2022
- Shares held
- 26.6M
- −423.4K (−1.6%) vs. Q3 2022
- Total value
- $20.2M
- +$3.09M (+18.1%) vs. Q3 2022
- New holders
- 9
- 8 more added
- Sold out
- 9
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 210 | $0 | 0.00% | −33−13.6% | Reduced |
| Royal Bank of Canada | 15 | $0 | 0.00% | +15 | New |
| Bank of America Corp | 151 | $114 | 0.00% | +151 | New |
| BNP Paribas Arbitrage, SA | 353 | $267 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 429 | $324 | 0.00% | +20+4.9% | Added |
| Allworth Financial LP | 800 | $605 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,500 | $1.13K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 8,000 | $5.28K | 0.00% | 00.0% | Unchanged |
| Stratos Wealth Partners, LTD. | 10,489 | $7.93K | 0.00% | 00.0% | Unchanged |
| ACT Advisors, LLC. | 13,866 | $10.5K | 0.01% | +13,866 | New |
| StoneX Group Inc. | 15,000 | $11.3K | 0.00% | +15,000 | New |
| Fisher Asset Management, LLC | 16,500 | $12.0K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 17,100 | $12.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 21,436 | $16.0K | 0.00% | +8,613+67.2% | Added |
| Two Sigma Advisers, LP | 25,800 | $19.5K | 0.00% | −2,400−8.5% | Reduced |
| Level Four Advisory Services, LLC | 27,927 | $21.1K | 0.00% | +27,927 | New |
| Aveo Capital Partners, LLC | 42,502 | $32.1K | 0.00% | 00.0% | Unchanged |
| Money Concepts Capital Corp | 55,000 | $41.6K | 0.00% | +55,000 | New |
| Prudential Financial Inc | 61,200 | $46.3K | 0.00% | +7,200+13.3% | Added |
| Jane Street Group, LLC | 62,482 | $47.3K | 0.00% | +62,482 | New |
| Goldman Sachs Group Inc | 67,097 | $50.7K | 0.00% | −5,294−7.3% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 73,655 | $55.7K | 0.00% | −15,031−16.9% | Reduced |
| Callan Capital, LLC | 103,462 | $78.2K | 0.01% | +103,462 | New |
| Northern Trust Corp | 105,490 | $79.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 132,466 | $100.2K | 0.00% | −64,143−32.6% | Reduced |
| Tocqueville Asset Management L.P. | 136,000 | $102.9K | 0.00% | +32,000+30.8% | Added |
| Jeppson Wealth Management, LLC | 160,610 | $121.5K | 0.05% | −13,565−7.8% | Reduced |
| Artal Group S.A. | 224,675 | $170.0K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 230,937 | $174.7K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 262,072 | $198.2K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 301,612 | $228.1K | 0.00% | +301,612 | New |
| West Family Investments, Inc. | 368,910 | $279.0K | 0.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 592,724 | $448.0K | 0.00% | +7,743+1.3% | Added |
| Millennium Management LLC | 689,917 | $522.0K | 0.00% | +606,201+724.1% | Added |
| 5AM Venture Management, LLC | 1,134,511 | $858.0K | 0.23% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 1,185,373 | $896.0K | 0.00% | −107,900−8.3% | Reduced |
| Acadian Asset Management LLC | 1,256,602 | $948.0K | 0.00% | +43,071+3.5% | Added |
| Alethea Capital Management, LLC | 1,677,194 | $1.27M | 1.22% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,469,150 | $1.87M | 0.00% | +1,2170.0% | Added |
| Point72 Asset Management, L.P. | 3,868,006 | $2.93M | 0.01% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 4,367,464 | $3.30M | 0.30% | −191,737−4.2% | Reduced |
| BVF Inc | 6,861,127 | $5.19M | 0.22% | 00.0% | Unchanged |
| Knott David M Jr | 0 | $0 | 0.00% | −686,027−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −369,099−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −41,819−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,889−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −17,001−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −11,672−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −405−100.0% | Sold out |